PG · Procter & Gamble Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $84.28B | $84.04B | $82.01B | $80.19B | $76.12B | $70.95B |
| Cost of Revenue | $41.16B | $40.85B | $42.76B | $42.16B | $37.11B | $35.25B |
| Gross Profit | $43.12B | $43.19B | $39.25B | $38.03B | $39.01B | $35.70B |
| R&D | $2.10B | $2.00B | $2.00B | $2.00B | $1.90B | $1.80B |
| SG&A | $22.67B | $23.30B | $21.11B | $20.22B | $21.02B | $19.99B |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $2.85B | $2.90B | $2.71B | $2.81B | $2.73B | $3.01B |
| Operating Income | $20.45B | $18.55B | $18.13B | $17.81B | $17.99B | $15.71B |
| Interest Expense | $907.00M | $925.00M | $756.00M | $439.00M | $502.00M | $465.00M |
| Income Tax | $4.10B | $3.79B | $3.62B | $3.20B | $3.26B | $2.73B |
| Net Income | $15.97B | $14.88B | $14.65B | $14.74B | $14.31B | $13.03B |
| EPS - Basic | $6.67 | $6.18 | $6.07 | $6.00 | $5.69 | $5.13 |
| EPS - Diluted | $6.51 | $6.02 | $5.90 | $5.81 | $5.50 | $4.96 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.56B | $9.48B | $8.25B | $7.21B | $10.29B | $5.57B |
| Accounts Receivable | $6.18B | $6.12B | $5.47B | $5.14B | $4.72B | $4.18B |
| Inventory | $7.55B | $7.02B | $7.07B | $6.92B | $5.98B | $5.50B |
| Accounts Payable | $15.23B | $15.36B | $14.60B | $14.88B | $13.72B | $12.07B |
| Current Assets | $25.39B | $24.71B | $22.65B | $21.65B | $23.09B | $27.99B |
| Total Assets | $125.23B | $122.37B | $120.83B | $117.21B | $119.31B | $120.70B |
| Current Liabilities | $36.06B | $33.63B | $35.76B | $33.08B | $33.13B | $32.98B |
| Long-term Debt | $25.00B | $25.27B | $24.38B | $22.85B | $23.10B | $23.54B |
| Total Liabilities | $72.95B | $71.81B | $73.76B | $70.35B | $72.65B | $73.82B |
| Stockholders' Equity | $52.28B | $50.56B | $47.06B | $46.85B | $46.65B | $46.88B |
| Retained Earnings | $129.97B | $123.81B | $118.17B | $112.43B | $106.37B | $100.24B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.82B | $19.85B | $16.85B | $16.72B | $18.37B | $17.40B |
| Investing Cash Flow | ($3.82B) | ($3.50B) | ($3.50B) | ($4.42B) | ($2.83B) | $3.04B |
| Financing Cash Flow | ($14.04B) | ($14.86B) | ($12.15B) | ($14.88B) | ($21.53B) | ($8.37B) |
| CapEx | $3.77B | $3.32B | $3.06B | $3.16B | $2.79B | $3.07B |
| Free Cash Flow | $14.04B | $16.52B | $13.79B | $13.57B | $15.58B | $14.33B |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 51.2% | 51.4% | 47.9% | 47.4% | 51.2% | 50.3% |
| Operating margin | 24.3% | 22.1% | 22.1% | 22.2% | 23.6% | 22.1% |
| EBITDA margin | 27.6% | 25.5% | 25.4% | 25.7% | 27.2% | 26.4% |
| Net margin | 19.0% | 17.7% | 17.9% | 18.4% | 18.8% | 18.4% |
| Free cash flow margin | 16.7% | 19.7% | 16.8% | 16.9% | 20.5% | 20.2% |
| FCF / Net income | 0.88 | 1.11 | 0.94 | 0.92 | 1.09 | 1.10 |
| R&D / Revenue | 2.5% | 2.4% | 2.4% | 2.5% | 2.5% | 2.5% |
| SG&A / Revenue | 26.9% | 27.7% | 25.7% | 25.2% | 27.6% | 28.2% |
| Effective tax rate | 20.4% | 20.3% | 19.8% | 17.8% | 18.6% | 17.3% |
| Return on assets | 12.8% | 12.2% | 12.1% | 12.6% | 12.0% | 10.8% |
| Return on equity | 30.6% | 29.4% | 31.1% | 31.5% | 30.7% | 27.8% |
| Return on invested capital | 21.1% | 19.5% | 20.4% | 21.0% | 21.0% | 18.4% |
| Liquidity | ||||||
| Current ratio | 0.70 | 0.73 | 0.63 | 0.65 | 0.70 | 0.85 |
| Quick ratio | 0.49 | 0.53 | 0.44 | 0.45 | 0.52 | 0.68 |
| Cash ratio | 0.27 | 0.28 | 0.23 | 0.22 | 0.31 | 0.17 |
| Leverage | ||||||
| Debt / Equity | 0.48 | 0.50 | 0.52 | 0.49 | 0.50 | 0.50 |
| Debt / Assets | 0.20 | 0.21 | 0.20 | 0.19 | 0.19 | 0.20 |
| Debt / EBITDA | 1.07 | 1.18 | 1.17 | 1.11 | 1.11 | 1.26 |
| Interest coverage | 22.5x | 20.0x | 24.0x | 40.6x | 35.8x | 33.8x |
| Equity multiplier | 2.40 | 2.42 | 2.57 | 2.50 | 2.56 | 2.57 |
| Liabilities / Assets | 0.58 | 0.59 | 0.61 | 0.60 | 0.61 | 0.61 |
| Efficiency | ||||||
| Asset turnover | 0.67 | 0.69 | 0.68 | 0.68 | 0.64 | 0.59 |
| Inventory turnover | 5.45 | 5.82 | 6.05 | 6.09 | 6.20 | 6.41 |
| Days sales outstanding | 27d | 27d | 24d | 23d | 23d | 21d |
| Days inventory outstanding | 67d | 63d | 60d | 60d | 59d | 57d |
| Days payable outstanding | 135d | 137d | 125d | 129d | 135d | 125d |
| Cash conversion cycle | -41d | -48d | -40d | -45d | -53d | -47d |
| Valuation | ||||||
| P / E | 24.5x | 27.4x | 25.7x | 24.7x | 24.5x | 24.1x |
| P / B | 7.5x | 8.1x | 8.0x | 7.8x | 7.5x | 6.7x |
| P / S | 4.6x | 4.9x | 4.6x | 4.6x | 4.6x | 4.4x |
| EV / EBITDA | 17.4x | 19.7x | 18.9x | 18.5x | 17.6x | 17.7x |
| Growth | ||||||
| Revenue growth (YoY) | 0.3% | 2.5% | 2.3% | 5.3% | 7.3% | 9.1% |
| Revenue CAGR (3y) | 1.7% | 3.4% | 4.9% | 7.2% | 4.4% | 2.9% |
| Revenue CAGR (5y) | 3.5% | 5.3% | 4.2% | 4.3% | 3.1% | -1.4% |
| Gross profit growth (YoY) | -0.2% | 10.1% | 3.2% | -2.5% | 9.3% | 10.1% |
| Operating income growth (YoY) | 10.3% | 2.3% | 1.8% | -1.0% | 14.5% | 186.2% |
| Net income growth (YoY) | 7.4% | 1.5% | -0.6% | 3.0% | 9.8% | 234.3% |
| EPS growth (YoY) | 8.1% | 2.0% | 1.5% | 5.6% | 10.9% | 246.9% |
| EPS CAGR (3y) | 3.9% | 3.1% | 6.0% | 59.6% | 14.4% | -3.9% |
| EPS CAGR (5y) | 5.6% | 33.3% | 10.0% | 0.8% | 8.3% | 15.2% |
| FCF growth (YoY) | -15.0% | 19.9% | 1.6% | -12.9% | 8.8% | 20.5% |
| FCF CAGR (5y) | -0.4% | 6.8% | 4.3% | 7.7% | 5.2% | 5.7% |
| Book value growth (YoY) | 3.4% | 7.4% | 0.5% | 0.4% | -0.5% | -1.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-06-30.
Business segments
$83.49B totalFabric Home Care Segment$29.62B · 35.5%
Baby Feminine Family Care Segment$20.25B · 24.3%
Beauty Segment$14.96B · 17.9%
Health Care Segment$12.00B · 14.4%
Grooming Segment$6.66B · 8.0%
Geographic
$84.30B totalNon Us$42.70B · 50.7%
US$41.60B · 49.3%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
2.30
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Comparing PROCTER & GAMBLE Co against the 5 most active filers in the same SIC group.
Dividends
$4.26/share trailing 12 months · +4.5% YoY
| Ex-date | Per share |
|---|---|
| Apr 24, 2026 | $1.0890 |
| Jan 23, 2026 | $1.0570 |
| Oct 24, 2025 | $1.0570 |
| Jul 18, 2025 | $1.0570 |
| Apr 21, 2025 | $1.0570 |
| Jan 24, 2025 | $1.0070 |
| Oct 18, 2024 | $1.0070 |
| Jul 19, 2024 | $1.0070 |
| Apr 18, 2024 | $1.0070 |
| Jan 18, 2024 | $0.9410 |
| Oct 19, 2023 | $0.9410 |
| Jul 20, 2023 | $0.9410 |
| Apr 20, 2023 | $0.9410 |
| Jan 19, 2023 | $0.9130 |
| Oct 20, 2022 | $0.9130 |
| Jul 21, 2022 | $0.9130 |
| Apr 21, 2022 | $0.9130 |
| Jan 20, 2022 | $0.8700 |
| Oct 21, 2021 | $0.8700 |
| Jul 22, 2021 | $0.8700 |
| Apr 22, 2021 | $0.8700 |
| Jan 21, 2021 | $0.7910 |
| Oct 22, 2020 | $0.7910 |
| Jul 23, 2020 | $0.7910 |